S'abonner

Sex-related differences in pulmonary physiologic outcome measures in a high-risk birth cohort - 06/08/15

Doi : 10.1016/j.jaci.2014.12.1927 
Amy O. Thomas, MD a, Daniel J. Jackson, MD a, , Michael D. Evans, MS b, Victoria Rajamanickam, MS b, Ronald E. Gangnon, PhD b, Sean B. Fain, PhD c, d, Ronald L. Sorkness, PhD a, e, f, Adesua Y. Okupa, MD a, Alex Thomas, MD a, James E. Gern, MD a, e, Robert F. Lemanske, MD a, e
a Department of Pediatrics, University of Wisconsin School of Medicine and Public Health, Madison, Wis 
b Department of Biostatistics and Medical Informatics, University of Wisconsin School of Medicine and Public Health, Madison, Wis 
c Department of Radiology, University of Wisconsin School of Medicine and Public Health, Madison, Wis 
d Department of Medical Physics, University of Wisconsin School of Medicine and Public Health, Madison, Wis 
e Department of Medicine, University of Wisconsin School of Medicine and Public Health, Madison, Wis 
f Department of Pharmacy, University of Wisconsin School of Medicine and Public Health, Madison, Wis 

Corresponding author: Daniel J. Jackson, MD, Department of Pediatrics, Section of Allergy, Immunology and Rheumatology, University of Wisconsin School of Medicine and Public Health, K4/936 Clinical Sciences Center, 600 Highland Ave, Madison, WI 53792.

Abstract

Background

Sex influences the risk of wheezing illnesses and the prevalence of asthma throughout childhood.

Objective

To better understand the mechanisms of these effects, we analyzed longitudinal relationships between sex, lung physiology, and asthma in the Childhood Origins of ASThma birth cohort study.

Methods

Childhood Origins of ASThma birth cohort study children were followed prospectively from birth and assessed annually. Results of spirometry, fractional exhaled nitric oxide (Feno), mannitol provocation testing, and 3He gas magnetic resonance imaging were assessed by sex using multivariate models including age, asthma diagnosis, and wheezing histories.

Results

Girls had higher prebronchodilator forced expiratory volume in 0.5 seconds/forced vital capacity values than did boys (mean difference, 0.017; 95% CI, 0.000-0.034; P = .05) of equivalent age. Postbronchodilator findings were more pronounced, with boys demonstrating reduced forced expiratory volume in 0.5 seconds/forced vital capacity values than did girls of equivalent age (mean difference, 0.032; 95% CI, 0.014-0.049; P = .0005). Conversely, girls were noted to have higher ventilation defects on 3He magnetic resonance imaging than did boys (P = .01). No differences were noted in the rate of positive responses to mannitol provocation or Feno measurements.

Conclusions

Lower airflow values are present by spirometry for prepubertal boys than for age-matched girls; however, greater 3He ventilation defects were noted in girls. This could represent a greater degree of subclinical air trapping in prepubertal girls because residual volumes are not detected on standard spirometric readings. No differences were noted between the 2 sexes with airway hyperresponsiveness (mannitol provocation testing) or inflammation (Feno). Prospective peripubertal follow-up will determine whether these differences persist or change with the de novo expression and remission of asthma based on sex and age.

Le texte complet de cet article est disponible en PDF.

Key words : Sex, gender, asthma, pulmonary physiology, spirometry, helium MRI, ventilation defects, mannitol, airway hyperreactivity, fractional exhaled nitric oxide

Abbreviations used : COAST, Feno, FEV0.5, FVC, MRI


Plan


 This study was supported by the National Institutes of Health (NIH) (grant no. P01 HL70831) and by the Clinical and Translational Science Award program through the NIH National Center for Advancing Translational Sciences (grant no. UL1TR000427).
 Disclosure of potential conflict of interest: D. J. Jackson has received research support from the National Heart, Lung, and Blood Institute (NHLBI) and has received consultancy fees from GlaxoSmithKline and Genentech. S. B. Fain has received research support from GE Healthcare. J. E. Gern has received research support from the National Institutes of Health, GlaxoSmithKline, and Merck and has received consultancy fees from GlaxoSmithKline, Johnson & Johnson, Merck, MedImmune, Boehringer Ingelheim, and Gilead. R. F. Lemanske, Jr reports grants from the University of Wisconsin, the NHLBI, and Pharmaxis and personal fees from the University of Wisconsin, Merck, Sepracor, SA Boney and Associates, GlaxoSmithKline, the American Institute of Research, Genentech, Double Helix Development, Boehringer Ingelheim, Michigan Public Health, Allegheny General Hospital, American Academy of Pediatrics, West Allegheny Health, California Chapter 4, the Colorado Allergy Society, the Pennsylvania Allergy Society, Howard Pilgrim Health, the California Society of Allergy, the NYC Allergy Society, the World Allergy Organization, Asia Pacific Association of Pediatric Allergy, Respirology and Immunology, the Western Society of Allergy, Asthma, and Immunology, the American Academy of Allergy, Asthma & Immunology, Elsevier, UpToDate, the Kuwait Allergy Society, Lurie Children's Hospital, Boston Children's Hospital, Health Star Communications, LA Children's Hospital, and Northwestern University. The rest of the authors declare that they have no relevant conflicts of interest.


© 2015  American Academy of Allergy, Asthma & Immunology. Publié par Elsevier Masson SAS. Tous droits réservés.
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Vol 136 - N° 2

P. 282-287 - août 2015 Retour au numéro
Article précédent Article précédent
  • Measuring the corticosteroid responsiveness endophenotype in asthmatic patients
  • George L. Clemmer, Ann Chen Wu, Bernard Rosner, Michael J. McGeachie, Augusto A. Litonjua, Kelan G. Tantisira, Scott T. Weiss
| Article suivant Article suivant
  • Risk of an asthma exacerbation after bariatric surgery in adults
  • Kohei Hasegawa, Yusuke Tsugawa, Yuchiao Chang, Carlos A. Camargo

Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.

Déjà abonné à cette revue ?

Elsevier s'engage à rendre ses eBooks accessibles et à se conformer aux lois applicables. Compte tenu de notre vaste bibliothèque de titres, il existe des cas où rendre un livre électronique entièrement accessible présente des défis uniques et l'inclusion de fonctionnalités complètes pourrait transformer sa nature au point de ne plus servir son objectif principal ou d'entraîner un fardeau disproportionné pour l'éditeur. Par conséquent, l'accessibilité de cet eBook peut être limitée. Voir plus

Mon compte


Plateformes Elsevier Masson

Déclaration CNIL

EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.

En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.


Tout le contenu de ce site: Copyright © 2026 Elsevier, ses concédants de licence et ses contributeurs. Tout les droits sont réservés, y compris ceux relatifs à l'exploration de textes et de données, a la formation en IA et aux technologies similaires. Pour tout contenu en libre accès, les conditions de licence Creative Commons s'appliquent.